Alphabet's Verily gets ECG clearance for Study Watch, signaling bigger health plans
It's a big week for Google's wearable plans. Following news that it's paying $40 million for Fossil technology, parent company Alphabet announced it's obtained FDA clearance for its electrocardiogram (ECG) wearable, the Study Watch. The Study Watch, if you recall, is a prescription-only smartwatch used for clinical research purposes. The watch captures ECG, heart rate,…